Dose‐Adjusted EPOCH‐R and Mid‐Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement. (9th August 2016) - Chihara, Dai; Fowler, Nathan H.; Oki, Yasuhiro; Fanale, Michelle A.; Fayad, Luis E.; Westin, Jason R.; Hagemeister, Fredrick B.